NextCure, Inc.
NXTC
$8.21
-$0.07-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.59M | 3.27M | 2.96M | 2.81M | 3.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.02M | 10.11M | 9.76M | 8.95M | 27.29M |
| Operating Income | -10.02M | -10.11M | -9.76M | -8.95M | -27.29M |
| Income Before Tax | -14.89M | -9.80M | -9.44M | -8.62M | -26.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.89M | -9.80M | -9.44M | -8.62M | -26.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.89M | -9.80M | -9.44M | -8.62M | -26.81M |
| EBIT | -10.02M | -10.11M | -9.76M | -8.95M | -27.29M |
| EBITDA | -9.75M | -9.82M | -9.39M | -8.41M | -26.66M |
| EPS Basic | -2.80 | -1.87 | -2.37 | -3.22 | -11.29 |
| Normalized Basic EPS | -1.16 | -1.17 | -1.48 | -2.01 | -7.06 |
| EPS Diluted | -2.80 | -1.87 | -2.37 | -3.22 | -11.29 |
| Normalized Diluted EPS | -1.16 | -1.17 | -1.48 | -2.01 | -7.06 |
| Average Basic Shares Outstanding | 5.31M | 5.24M | 3.98M | 2.68M | 2.37M |
| Average Diluted Shares Outstanding | 5.31M | 5.24M | 3.98M | 2.68M | 2.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |